Myovant Sciences EBITDA 2017-2022 | MYOV
Myovant Sciences ebitda from 2017 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Myovant Sciences Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-182 |
| 2021 | $-258 |
| 2020 | $-272 |
| 2019 | $-262 |
| 2018 | $-140 |
| 2017 | $-56 |
| 2016 | $-2 |
| Myovant Sciences Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2022-12-31 | $-51 |
| 2022-09-30 | $-33 |
| 2022-06-30 | $-9 |
| 2022-03-31 | $-49 |
| 2021-12-31 | $-59 |
| 2021-09-30 | $-18 |
| 2021-06-30 | $-57 |
| 2021-03-31 | $-76 |
| 2020-12-31 | $-78 |
| 2020-09-30 | $-71 |
| 2020-06-30 | $-33 |
| 2020-03-31 | $-64 |
| 2019-12-31 | $-77 |
| 2019-09-30 | $-66 |
| 2019-06-30 | $-64 |
| 2019-03-31 | $-71 |
| 2018-12-31 | $-69 |
| 2018-09-30 | $-64 |
| 2018-06-30 | $-59 |
| 2018-03-31 | $-47 |
| 2017-12-31 | $-41 |
| 2017-09-30 | $-30 |
| 2017-06-30 | $-22 |
| 2017-03-31 | $-23 |
| 2016-12-31 | $-9 |
| 2016-09-30 | $-7 |
| 2016-06-30 | $-17 |
